JPS58216180A - エポキシ化プレビタミンｄ↓３ - Google Patents
エポキシ化プレビタミンｄ↓３Info
- Publication number
- JPS58216180A JPS58216180A JP57099377A JP9937782A JPS58216180A JP S58216180 A JPS58216180 A JP S58216180A JP 57099377 A JP57099377 A JP 57099377A JP 9937782 A JP9937782 A JP 9937782A JP S58216180 A JPS58216180 A JP S58216180A
- Authority
- JP
- Japan
- Prior art keywords
- previtamin
- epoxidized
- formula
- reaction
- butyl hydroperoxide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- YUGCAAVRZWBXEQ-UHFFFAOYSA-N Precholecalciferol Natural products C=1CCC2(C)C(C(C)CCCC(C)C)CCC2C=1C=CC1=C(C)CCC(O)C1 YUGCAAVRZWBXEQ-UHFFFAOYSA-N 0.000 title claims abstract 4
- YUGCAAVRZWBXEQ-WHTXLNIXSA-N previtamin D3 Chemical compound C=1([C@@H]2CC[C@@H]([C@]2(CCC=1)C)[C@H](C)CCCC(C)C)\C=C/C1=C(C)CC[C@H](O)C1 YUGCAAVRZWBXEQ-WHTXLNIXSA-N 0.000 title claims abstract 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 abstract description 6
- CIHOLLKRGTVIJN-UHFFFAOYSA-N tert‐butyl hydroperoxide Chemical compound CC(C)(C)OO CIHOLLKRGTVIJN-UHFFFAOYSA-N 0.000 abstract description 4
- 229910052750 molybdenum Inorganic materials 0.000 abstract description 3
- 239000011733 molybdenum Substances 0.000 abstract description 3
- 210000004027 cell Anatomy 0.000 abstract description 2
- 230000004069 differentiation Effects 0.000 abstract description 2
- 239000003814 drug Substances 0.000 abstract description 2
- 210000003714 granulocyte Anatomy 0.000 abstract description 2
- 229910017333 Mo(CO)6 Inorganic materials 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 239000007810 chemical reaction solvent Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 208000025113 myeloid leukemia Diseases 0.000 abstract 1
- 150000002978 peroxides Chemical class 0.000 abstract 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 abstract 1
- 235000005282 vitamin D3 Nutrition 0.000 abstract 1
- 239000011647 vitamin D3 Substances 0.000 abstract 1
- 229940021056 vitamin d3 Drugs 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 description 4
- 239000002904 solvent Substances 0.000 description 3
- 238000005406 washing Methods 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 230000000010 osteolytic effect Effects 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Landscapes
- Epoxy Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57099377A JPS58216180A (ja) | 1982-06-11 | 1982-06-11 | エポキシ化プレビタミンｄ↓３ |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57099377A JPS58216180A (ja) | 1982-06-11 | 1982-06-11 | エポキシ化プレビタミンｄ↓３ |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS58216180A true JPS58216180A (ja) | 1983-12-15 |
| JPH0318627B2 JPH0318627B2 (enrdf_load_stackoverflow) | 1991-03-13 |
Family
ID=14245830
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP57099377A Granted JPS58216180A (ja) | 1982-06-11 | 1982-06-11 | エポキシ化プレビタミンｄ↓３ |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS58216180A (enrdf_load_stackoverflow) |
-
1982
- 1982-06-11 JP JP57099377A patent/JPS58216180A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0318627B2 (enrdf_load_stackoverflow) | 1991-03-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2392999A1 (fr) | Nouveaux derives de l'acide 6-((aminosulfonyl)-phenyl)-1,2-dihydro-2-oxonicotinique utile comme medicament | |
| ATE4169T1 (de) | Antacidum auf der basis von magnesium-aluminium- hydroxyd und seine herstellung. | |
| Slocum et al. | The preparation of several N-Substituted and N, N-Disubstituted ferrocenesulfonamides | |
| JPS58216180A (ja) | エポキシ化プレビタミンｄ↓３ | |
| JPS58216178A (ja) | ５，６−エポキシ化ビタミンｄ↓３誘導体 | |
| JPH0211563A (ja) | １β−ヒドロキシビタミンＤ↓２およびＤ↓３の製造方法 | |
| Williams et al. | Three-step synthesis of methyl sterculate | |
| JPS60502203A (ja) | １，２３−ジヒドロキシビタミンｄ化合物 | |
| Squadrito et al. | [52] Synthesis of inflammatory signal transduction species formed during ozonation and/or peroxidation of tissue lipids | |
| JPS58206554A (ja) | 新規なポリプレニル化合物 | |
| SU690002A1 (ru) | Способ получени 4-метокси-1,2нафтохинона | |
| JPS58216179A (ja) | ７，８−エポキシ化ビタミンｄ↓３誘導体 | |
| JPS59190962A (ja) | ２４−オキソ−２５−デヒドロビタミンｄ↓３類、その製造法及びそれを有効成分とするカルシウム調節剤 | |
| JPS59157080A (ja) | 新規のオキサスピロドデカン−誘導体、その製造法及びこれを含有する香料 | |
| JPS5877833A (ja) | （＋）−または（−）−７−ヒドロキシメチル−２，６，６−トリメチル−トリシクロ〔６，２，１，０１，５〕ウンデカン | |
| JPS59101458A (ja) | 新規なチアプロスタグランジン誘導体及びその製法 | |
| Morris et al. | AN IMPROVED STEREOSELECTIVE REDUCTION FOR THE PREPARATION OF endo-7-PHENYLNORCARANE | |
| JPH039892B2 (enrdf_load_stackoverflow) | ||
| JPS59219279A (ja) | 血小板凝集阻止剤 | |
| JPS5832850A (ja) | スルホシステイン誘導体 | |
| JPS591435A (ja) | オルト蟻酸トリメチル又はトリエチルエステルの製造法 | |
| JPS5855440A (ja) | アセタ−ルの製造方法 | |
| Richards | The Reaction of Dimethyl-and Di-n-butylcopper Lithium with 3-Bromo-2-(2-phenylacetamido) acrylic Acid | |
| JPS6010007B2 (ja) | 香料組成物 | |
| JPS60172960A (ja) | 新規なビタミンｄ↓３誘導体 |